Connect with us

International

Frenemies Talk, but Progess is Elusive

Overview:  The US dollar is paring this week’s gains, retreating against most of the major and emerging market currencies today amid a risk-on mood.  Inconclusive talks between Biden and Xi, the first direct communication in more than six months, and…

Published

on

Overview:  The US dollar is paring this week's gains, retreating against most of the major and emerging market currencies today amid a risk-on mood.  Inconclusive talks between Biden and Xi, the first direct communication in more than six months, and Beijing's clarification that it will slow but not freeze new game approvals were cited as drivers.  The dollar-bloc currencies and the Norweigan krone are leading today's move, but the Australian and Canadian dollars remain the poorest performers on the week.  The JP Morgan Emerging Market Currency Index is posting small gains for the second day but is off about 0.6% for the week ahead of the Latam open.  Japan and Hong Kong equity markets gained more than 1% to lead the MSCI Asia Pacific Index higher.  It managed a small gain on the week after more than 3.3% advances in each of the past two weeks.  Europe's Dow Jones Stoxx 600 is edging higher to snap a three-day 1.6% fall.  US futures are recouping yesterday's slide.  European and US benchmark 10-year yields are 1-2 bp higher, leaving the US Treasury yield at 1.32%, virtually unchanged on the week.  The UK's 10-year Gilt yield is flat today after disappointing July data, but its 4.5 bp rise this week is the most of the major markets.  Gold is trading at its best level in three days, trying to re-establish a foothold above $1800.   Oil is winding down a choppy week on an up note. October crude oil lost nearly 1.7% yesterday and has recouped it in full today. For the week, it is also flat for all practical purposes.  China's iron ore futures contract slipped today to record a 5.5% loss for the week after dropping 6.6% last week.  On the other hand, copper is up about 1.5% today after a 1.2% gain yesterday, which is enough to turn it higher for the week (~0.5%).  The CRB Index is off by about 0.75% for the week coming into today.  

Asia Pacific

There are three Chinese developments to note:  Beijing tapping its strategic oil reserves, bilateral talk with the US, and the latest lending figures.  First, China has already auctioned some of its strategic industrial metal holdings to end-users.  Yesterday, it announced it would provide oil from its holdings in "batches" to domestic companies, apparently focusing on petrochemical producers.  Recall that earlier yesterday, China reported a new jump in producer prices.  The US media talked about this as evidence of China's statist approach, but that might not be a particularly useful framing.  The US, after all, does the same thing.  Just yesterday, it was announced the US would lend oil from its strategic reserves to Exxon to help compensate for lost production in the Gulf.  The US fiscal plans also call for some liquidation of the strategic oil reserves, as if it were a piggy bank used to facilitate budget compromises.  The US has done the same thing in the past for some grains. More recently, the Biden administration lobbied (though the historian Tooze called in "bullying") OPEC to produce more oil but refrained from addressing the issue itself by releasing its strategic oil holdings to dampen the price.  

At President Biden's initiative, there was a call with China's Xi.  It was reportedly the first direct communication since February.  According to reports, the essence of the conversation was that Biden sought to secure Beijing's cooperation on the environment, and Xi sees such cooperation as an integral part of the larger relationship. The US wants to de-link issues, and China sees them more holistically. The Sino-American relationship is in disrepair, and today's call does not seem to change this.  The US appears to list actions it wants China to take, while China's demands seem minimalist.  Quit demonizing it and respect its red lines.  Yet its red lines strike at the very heart of the international order, such as its claims on most of the South China Sea and its aggressive provocative actions in the region.  

China's lending rose sharply in August as the financial purse strings opened and the economy lost more momentum.  New yuan loans, which are bank loans, rose by CNY1.22 trillion, above the CNY1.08 trillion in July, though not as much as the CNY1.4 trillion expected.  This was made up for by non-bank activity (shadow banking).  It jumped by CNY1.74 trillion after falling slightly in July.  This lifted the aggregate financing to CNY2.96 trillion, which was a bit more than expected, after a CNY1.06 trillion in July.  The takeaway here is that Beijing has become somewhat more accommodative but is reluctant to unveil a large program or the blunt instrument of interest rates, apparently preferring more modest measures and perhaps more targeted measures.  

The US dollar tested the lower end of its recent range against the yen yesterday near JPY109.60, and it has firmed to almost JPY110.00 today.  Today, a firm US PPI report could see the greenback test the JPY110.10-JPY110.25, where nearly $1.5 bln in expiring options have been struck.  They may prove a sufficient cap ahead of the weekend.  The Australian dollar is trading above $0.7400 for the first time in three days.  There is an option there for A$810 that expires today.   The $0.7410 and $0.7425 area are retracement targets of the drop since last Friday's test on the $0.7480 area.  The dollar is trading below the CNY6.45-level, which it has not closed below since mid-June.  It approached last week's spike low (September 3 ~CNY6.4335), but last week, it recovered in late dealing and settled near CNY6.4550. Meanwhile, the PBOC dollar fix was tight to expectations (CNY6.4566 vs. CNY6.4568). 

Europe

The ECB unanimously resolved to a "moderately lower" pace of bond purchases in Q4 from the roughly 80 bln euros a month in Q2 and Q3.  Although the ECB did not specify the precise amount of bonds it would buy, a Reuters report cited unnamed officials suggesting that it would be between 60 and 70 bln euros.  Remember, like the Bank of Japan, the ECB had a bond-buying program before the pandemic struck, and this program (APP) is at about a 20 bln euro a month pace.  It will continue after the PEPP "envelope" expires at the end of March.  It is the size and flexibility of the APP effort that seems to be the new contested terrain.  Many expect a new envelope for its will be approved.  The flexibility, such as how much it has to track the capital key or issuer limits, appears to be part of the discussion.  In terms of its forecasts, the ECB staff pushed up this year's growth forecast to 5.0% from 4.6% and shaved next year to 4.6% from 4.7%.  Its 2023 forecast was unchanged at 2.1%.  Inflation is a different story.  It boosted this year's forecast above 2%.  Although it tweaked next year's forecast higher (1.7%) and 2023 (1.5%), the fact is that both remain below 2%, and this is where the thin edge of the dovish thrust is evident.  As long as inflation is expected to undershoot the new symmetrical target, policy needs to be accommodative.  

Although the Bank of England's Bailey revealed that half of the MPC believes that the minimum condition for a rate hike exists, which has helped underpin sterling and UK rates, today's data disappointed.  Economists had expected July GDP to rise by 0.5%.  Instead, 0.1% growth was reported.  The weakness did not stem from industrial production, which grew by 1.2%, rather than the 0.4% economists anticipated.  The weakness was in construction (-1.6% vs. 0.5% expectations), and more importantly, in services (0.0 vs. 0.6% forecasts).  Trade was also a notable drag.  The deficit widened to GBP3.1 bln from GBP2.5 bln.  The median forecast in Bloomberg's survey was for a GBP1.6 bln shortfall.  Next week, the UK reports on the labor market (slow improvement), prices (sharp jump in CPI), and retail sales (a modest recovery after an unexpectedly large 2.5% decline in July). 

In the middle of the week, the euro set a high, slightly above $1.1850, and tested it again in the European morning.  It is providing sticky, and there are options for nearly 1.5 bln euros struck there that expires today.  Another set for around 965 mln at $1.1875 also expires today.  The euro settled last week close to $1.1880 to complete a six-day advance.  It fell in the first three sessions this week.  Support is seen ahead of $1.1800.  The disappointing data have prevented sterling from rising to a new high for the week near $1.3885.  Last week's high was a touch higher, though it has not traded above $1.3900 in a month. The upper Bollinger Band (two standard deviations above the 20-day moving average) comes in just above $1.3900.  After trying in vain for a couple of weeks to close above GBP0.8600, players looked to have given up, and the cross fell to GBP0.8525 yesterday, its lowest in nearly three weeks.  It is consolidating today.  

America

The US PPI typically does not draw the same attention as the CPI, which will be reported next Tuesday.  Yet, some contacts report keen interest in today's report.  It could be because there is little else to focus on ahead of the weekend.  It cannot really be surprising that US producer prices remain elevated.  Everyone seems to recognize it and China's PPI figures earlier this week provided more confirmation.  There are good reasons why central banks do not target PPI.  When it comes to headline and core inflation, it has been well-established that headline convergences to core historically in the US, not the other way around.  The relationship between producer prices and consumer prices is a different story.    

Canada reports August employment data today.  Recall that Canada lost full-time jobs in May and June before bouncing back in July (83k).  Canada appears to have emerged from the soft patch that produced an unexpected 1.1% contraction in Q2.  Although the central bank's preliminary projection showed the economy contracted again in July after expanding in June, the high-frequency data, including the July employment report, suggested a more upbeat outlook.  The median forecast in Bloomberg's survey calls for net job growth of 67.5k (94.0k in July), a small increase in the participation rate (65.3% vs. 65.2%), and a decline in the unemployment rate (7.3% vs.7.5%).  The Bank of Canada will update its forecasts and could announce more tapering at its next meeting on October 27.  

Mexico's August CPI was in line with expectations, with the headline slipping to 5.59% from 5.81%.  The core rate moderated but was still slightly firmer than expected.  Nevertheless, the comment from the central bank governor seemed to reinforce the sense that after hiking rates in July and August, the Banxico will pause when it meets later this month.  Today, July industrial production is on tap, and a small gain after June's 0.5% decline is expected. On the other hand, Brazil's August CPI rose more than expected (9.68% vs. 8.99% in July). The central bank meets on September 22 and is expected to continue to hike rates.  July retail sales will be reported today, and broad measures may have declined for the second consecutive month.  Lastly, as expected, Peru's central bank doubled its reference rate yesterday to 1.0%.  

The US dollar is unwinding the gains scored earlier this week against the Canadian dollar.  The greenback poked above CAD1.2760 in the middle of the week, its highest level in nearly three weeks.  It mostly consolidated yesterday and is moving lower today to test the CAD1.2600 area.  A convincing break would see a push toward CAD1.2550.  The nearly $900 mln of expiring options set in the CAD1.2510-CAD1.2515 area seems too far away to impact today.  The US dollar has traded quietly against the peso this week.  It has held below MXN20.00 and above MXN19.87.  Note that since August 26, the US dollar has settled only once higher (Sept 7).  It has fallen in 9 of the past 10 sessions coming into today, and it is nursing a loss of about 0.2% in Europe.  


Disclaimer 



Read More

Continue Reading

International

Red Candle In The Wind

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by…

Published

on

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by printing at 275,000 against a consensus call of 200,000. We say superficially, because the downward revisions to prior months totalled 167,000 for December and January, taking the total change in employed persons well below the implied forecast, and helping the unemployment rate to pop two-ticks to 3.9%. The U6 underemployment rate also rose from 7.2% to 7.3%, while average hourly earnings growth fell to 0.2% m-o-m and average weekly hours worked languished at 34.3, equalling pre-pandemic lows.

Undeterred by the devil in the detail, the algos sprang into action once exchanges opened. Market darling NVIDIA hit a new intraday high of $974 before (presumably) the humans took over and sold the stock down more than 10% to close at $875.28. If our suspicions are correct that it was the AIs buying before the humans started selling (no doubt triggering trailing stops on the way down), the irony is not lost on us.

The 1-day chart for NVIDIA now makes for interesting viewing, because the red candle posted on Friday presents quite a strong bearish engulfing signal. Volume traded on the day was almost double the 15-day simple moving average, and similar price action is observable on the 1-day charts for both Intel and AMD. Regular readers will be aware that we have expressed incredulity in the past about the durability the AI thematic melt-up, so it will be interesting to see whether Friday’s sell off is just a profit-taking blip, or a genuine trend reversal.

AI equities aside, this week ought to be important for markets because the BTFP program expires today. That means that the Fed will no longer be loaning cash to the banking system in exchange for collateral pledged at-par. The KBW Regional Banking index has so far taken this in its stride and is trading 30% above the lows established during the mini banking crisis of this time last year, but the Fed’s liquidity facility was effectively an exercise in can-kicking that makes regional banks a sector of the market worth paying attention to in the weeks ahead. Even here in Sydney, regulators are warning of external risks posed to the banking sector from scheduled refinancing of commercial real estate loans following sharp falls in valuations.

Markets are sending signals in other sectors, too. Gold closed at a new record-high of $2178/oz on Friday after trading above $2200/oz briefly. Gold has been going ballistic since the Friday before last, posting gains even on days where 2-year Treasury yields have risen. Gold bugs are buying as real yields fall from the October highs and inflation breakevens creep higher. This is particularly interesting as gold ETFs have been recording net outflows; suggesting that price gains aren’t being driven by a retail pile-in. Are gold buyers now betting on a stagflationary outcome where the Fed cuts without inflation being anchored at the 2% target? The price action around the US CPI release tomorrow ought to be illuminating.

Leaving the day-to-day movements to one side, we are also seeing further signs of structural change at the macro level. The UK budget last week included a provision for the creation of a British ISA. That is, an Individual Savings Account that provides tax breaks to savers who invest their money in the stock of British companies. This follows moves last year to encourage pension funds to head up the risk curve by allocating 5% of their capital to unlisted investments.

As a Hail Mary option for a government cruising toward an electoral drubbing it’s a curious choice, but it’s worth highlighting as cash-strapped governments increasingly see private savings pools as a funding solution for their spending priorities.

Of course, the UK is not alone in making creeping moves towards financial repression. In contrast to announcements today of increased trade liberalisation, Australian Treasurer Jim Chalmers has in the recent past flagged his interest in tapping private pension savings to fund state spending priorities, including defence, public housing and renewable energy projects. Both the UK and Australia appear intent on finding ways to open up the lungs of their economies, but government wants more say in directing private capital flows for state goals.

So, how far is the blurring of the lines between free markets and state planning likely to go? Given the immense and varied budgetary (and security) pressures that governments are facing, could we see a re-up of WWII-era Victory bonds, where private investors are encouraged to do their patriotic duty by directly financing government at negative real rates?

That would really light a fire under the gold market.

Tyler Durden Mon, 03/11/2024 - 19:00

Read More

Continue Reading

Government

Trump “Clearly Hasn’t Learned From His COVID-Era Mistakes”, RFK Jr. Says

Trump "Clearly Hasn’t Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President…

Published

on

Trump "Clearly Hasn't Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President Joe Biden claimed that COVID vaccines are now helping cancer patients during his State of the Union address on March 7, but it was a response on Truth Social from former President Donald Trump that drew the ire of independent presidential candidate Robert F. Kennedy Jr.

Robert F. Kennedy Jr. holds a voter rally in Grand Rapids, Mich., on Feb. 10, 2024. (Mitch Ranger for The Epoch Times)

During the address, President Biden said: “The pandemic no longer controls our lives. The vaccines that saved us from COVID are now being used to help beat cancer, turning setback into comeback. That’s what America does.”

President Trump wrote: “The Pandemic no longer controls our lives. The VACCINES that saved us from COVID are now being used to help beat cancer—turning setback into comeback. YOU’RE WELCOME JOE. NINE-MONTH APPROVAL TIME VS. 12 YEARS THAT IT WOULD HAVE TAKEN YOU.”

An outspoken critic of President Trump’s COVID response, and the Operation Warp Speed program that escalated the availability of COVID vaccines, Mr. Kennedy said on X, formerly known as Twitter, that “Donald Trump clearly hasn’t learned from his COVID-era mistakes.”

“He fails to recognize how ineffective his warp speed vaccine is as the ninth shot is being recommended to seniors. Even more troubling is the documented harm being caused by the shot to so many innocent children and adults who are suffering myocarditis, pericarditis, and brain inflammation,” Mr. Kennedy remarked.

“This has been confirmed by a CDC-funded study of 99 million people. Instead of bragging about its speedy approval, we should be honestly and transparently debating the abundant evidence that this vaccine may have caused more harm than good.

“I look forward to debating both Trump and Biden on Sept. 16 in San Marcos, Texas.”

Mr. Kennedy announced in April 2023 that he would challenge President Biden for the 2024 Democratic Party presidential nomination before declaring his run as an independent last October, claiming that the Democrat National Committee was “rigging the primary.”

Since the early stages of his campaign, Mr. Kennedy has generated more support than pundits expected from conservatives, moderates, and independents resulting in speculation that he could take votes away from President Trump.

Many Republicans continue to seek a reckoning over the government-imposed pandemic lockdowns and vaccine mandates.

President Trump’s defense of Operation Warp Speed, the program he rolled out in May 2020 to spur the development and distribution of COVID-19 vaccines amid the pandemic, remains a sticking point for some of his supporters.

Vice President Mike Pence (L) and President Donald Trump deliver an update on Operation Warp Speed in the Rose Garden of the White House in Washington on Nov. 13, 2020. (Mandel Ngan/AFP via Getty Images)

Operation Warp Speed featured a partnership between the government, the military, and the private sector, with the government paying for millions of vaccine doses to be produced.

President Trump released a statement in March 2021 saying: “I hope everyone remembers when they’re getting the COVID-19 Vaccine, that if I wasn’t President, you wouldn’t be getting that beautiful ‘shot’ for 5 years, at best, and probably wouldn’t be getting it at all. I hope everyone remembers!”

President Trump said about the COVID-19 vaccine in an interview on Fox News in March 2021: “It works incredibly well. Ninety-five percent, maybe even more than that. I would recommend it, and I would recommend it to a lot of people that don’t want to get it and a lot of those people voted for me, frankly.

“But again, we have our freedoms and we have to live by that and I agree with that also. But it’s a great vaccine, it’s a safe vaccine, and it’s something that works.”

On many occasions, President Trump has said that he is not in favor of vaccine mandates.

An environmental attorney, Mr. Kennedy founded Children’s Health Defense, a nonprofit that aims to end childhood health epidemics by promoting vaccine safeguards, among other initiatives.

Last year, Mr. Kennedy told podcaster Joe Rogan that ivermectin was suppressed by the FDA so that the COVID-19 vaccines could be granted emergency use authorization.

He has criticized Big Pharma, vaccine safety, and government mandates for years.

Since launching his presidential campaign, Mr. Kennedy has made his stances on the COVID-19 vaccines, and vaccines in general, a frequent talking point.

“I would argue that the science is very clear right now that they [vaccines] caused a lot more problems than they averted,” Mr. Kennedy said on Piers Morgan Uncensored last April.

“And if you look at the countries that did not vaccinate, they had the lowest death rates, they had the lowest COVID and infection rates.”

Additional data show a “direct correlation” between excess deaths and high vaccination rates in developed countries, he said.

President Trump and Mr. Kennedy have similar views on topics like protecting the U.S.-Mexico border and ending the Russia-Ukraine war.

COVID-19 is the topic where Mr. Kennedy and President Trump seem to differ the most.

Former President Donald Trump intended to “drain the swamp” when he took office in 2017, but he was “intimidated by bureaucrats” at federal agencies and did not accomplish that objective, Mr. Kennedy said on Feb. 5.

Speaking at a voter rally in Tucson, where he collected signatures to get on the Arizona ballot, the independent presidential candidate said President Trump was “earnest” when he vowed to “drain the swamp,” but it was “business as usual” during his term.

John Bolton, who President Trump appointed as a national security adviser, is “the template for a swamp creature,” Mr. Kennedy said.

Scott Gottlieb, who President Trump named to run the FDA, “was Pfizer’s business partner” and eventually returned to Pfizer, Mr. Kennedy said.

Mr. Kennedy said that President Trump had more lobbyists running federal agencies than any president in U.S. history.

“You can’t reform them when you’ve got the swamp creatures running them, and I’m not going to do that. I’m going to do something different,” Mr. Kennedy said.

During the COVID-19 pandemic, President Trump “did not ask the questions that he should have,” he believes.

President Trump “knew that lockdowns were wrong” and then “agreed to lockdowns,” Mr. Kennedy said.

He also “knew that hydroxychloroquine worked, he said it,” Mr. Kennedy explained, adding that he was eventually “rolled over” by Dr. Anthony Fauci and his advisers.

President Donald Trump greets the crowd before he leaves at the Operation Warp Speed Vaccine Summit in Washington on Dec. 8, 2020. (Tasos Katopodis/Getty Images)

MaryJo Perry, a longtime advocate for vaccine choice and a Trump supporter, thinks votes will be at a premium come Election Day, particularly because the independent and third-party field is becoming more competitive.

Ms. Perry, president of Mississippi Parents for Vaccine Rights, believes advocates for medical freedom could determine who is ultimately president.

She believes that Mr. Kennedy is “pulling votes from Trump” because of the former president’s stance on the vaccines.

“People care about medical freedom. It’s an important issue here in Mississippi, and across the country,” Ms. Perry told The Epoch Times.

“Trump should admit he was wrong about Operation Warp Speed and that COVID vaccines have been dangerous. That would make a difference among people he has offended.”

President Trump won’t lose enough votes to Mr. Kennedy about Operation Warp Speed and COVID vaccines to have a significant impact on the election, Ohio Republican strategist Wes Farno told The Epoch Times.

President Trump won in Ohio by eight percentage points in both 2016 and 2020. The Ohio Republican Party endorsed President Trump for the nomination in 2024.

“The positives of a Trump presidency far outweigh the negatives,” Mr. Farno said. “People are more concerned about their wallet and the economy.

“They are asking themselves if they were better off during President Trump’s term compared to since President Biden took office. The answer to that question is obvious because many Americans are struggling to afford groceries, gas, mortgages, and rent payments.

“America needs President Trump.”

Multiple national polls back Mr. Farno’s view.

As of March 6, the RealClearPolitics average of polls indicates that President Trump has 41.8 percent support in a five-way race that includes President Biden (38.4 percent), Mr. Kennedy (12.7 percent), independent Cornel West (2.6 percent), and Green Party nominee Jill Stein (1.7 percent).

A Pew Research Center study conducted among 10,133 U.S. adults from Feb. 7 to Feb. 11 showed that Democrats and Democrat-leaning independents (42 percent) are more likely than Republicans and GOP-leaning independents (15 percent) to say they have received an updated COVID vaccine.

The poll also reported that just 28 percent of adults say they have received the updated COVID inoculation.

The peer-reviewed multinational study of more than 99 million vaccinated people that Mr. Kennedy referenced in his X post on March 7 was published in the Vaccine journal on Feb. 12.

It aimed to evaluate the risk of 13 adverse events of special interest (AESI) following COVID-19 vaccination. The AESIs spanned three categories—neurological, hematologic (blood), and cardiovascular.

The study reviewed data collected from more than 99 million vaccinated people from eight nations—Argentina, Australia, Canada, Denmark, Finland, France, New Zealand, and Scotland—looking at risks up to 42 days after getting the shots.

Three vaccines—Pfizer and Moderna’s mRNA vaccines as well as AstraZeneca’s viral vector jab—were examined in the study.

Researchers found higher-than-expected cases that they deemed met the threshold to be potential safety signals for multiple AESIs, including for Guillain-Barre syndrome (GBS), cerebral venous sinus thrombosis (CVST), myocarditis, and pericarditis.

A safety signal refers to information that could suggest a potential risk or harm that may be associated with a medical product.

The study identified higher incidences of neurological, cardiovascular, and blood disorder complications than what the researchers expected.

President Trump’s role in Operation Warp Speed, and his continued praise of the COVID vaccine, remains a concern for some voters, including those who still support him.

Krista Cobb is a 40-year-old mother in western Ohio. She voted for President Trump in 2020 and said she would cast her vote for him this November, but she was stunned when she saw his response to President Biden about the COVID-19 vaccine during the State of the Union address.

I love President Trump and support his policies, but at this point, he has to know they [advisers and health officials] lied about the shot,” Ms. Cobb told The Epoch Times.

“If he continues to promote it, especially after all of the hearings they’ve had about it in Congress, the side effects, and cover-ups on Capitol Hill, at what point does he become the same as the people who have lied?” Ms. Cobb added.

“I think he should distance himself from talk about Operation Warp Speed and even admit that he was wrong—that the vaccines have not had the impact he was told they would have. If he did that, people would respect him even more.”

Tyler Durden Mon, 03/11/2024 - 17:00

Read More

Continue Reading

International

There will soon be one million seats on this popular Amtrak route

“More people are taking the train than ever before,” says Amtrak’s Executive Vice President.

Published

on

While the size of the United States makes it hard for it to compete with the inter-city train access available in places like Japan and many European countries, Amtrak trains are a very popular transportation option in certain pockets of the country — so much so that the country’s national railway company is expanding its Northeast Corridor by more than one million seats.

Related: This is what it's like to take a 19-hour train from New York to Chicago

Running from Boston all the way south to Washington, D.C., the route is one of the most popular as it passes through the most densely populated part of the country and serves as a commuter train for those who need to go between East Coast cities such as New York and Philadelphia for business.

Veronika Bondarenko captured this photo of New York’s Moynihan Train Hall. 

Veronika Bondarenko

Amtrak launches new routes, promises travelers ‘additional travel options’

Earlier this month, Amtrak announced that it was adding four additional Northeastern routes to its schedule — two more routes between New York’s Penn Station and Union Station in Washington, D.C. on the weekend, a new early-morning weekday route between New York and Philadelphia’s William H. Gray III 30th Street Station and a weekend route between Philadelphia and Boston’s South Station.

More Travel:

According to Amtrak, these additions will increase Northeast Corridor’s service by 20% on the weekdays and 10% on the weekends for a total of one million additional seats when counted by how many will ride the corridor over the year.

“More people are taking the train than ever before and we’re proud to offer our customers additional travel options when they ride with us on the Northeast Regional,” Amtrak Executive Vice President and Chief Commercial Officer Eliot Hamlisch said in a statement on the new routes. “The Northeast Regional gets you where you want to go comfortably, conveniently and sustainably as you breeze past traffic on I-95 for a more enjoyable travel experience.”

Here are some of the other Amtrak changes you can expect to see

Amtrak also said that, in the 2023 financial year, the Northeast Corridor had nearly 9.2 million riders — 8% more than it had pre-pandemic and a 29% increase from 2022. The higher demand, particularly during both off-peak hours and the time when many business travelers use to get to work, is pushing Amtrak to invest into this corridor in particular.

To reach more customers, Amtrak has also made several changes to both its routes and pricing system. In the fall of 2023, it introduced a type of new “Night Owl Fare” — if traveling during very late or very early hours, one can go between cities like New York and Philadelphia or Philadelphia and Washington. D.C. for $5 to $15.

As travel on the same routes during peak hours can reach as much as $300, this was a deliberate move to reach those who have the flexibility of time and might have otherwise preferred more affordable methods of transportation such as the bus. After seeing strong uptake, Amtrak added this type of fare to more Boston routes.

The largest distances, such as the ones between Boston and New York or New York and Washington, are available at the lowest rate for $20.

Read More

Continue Reading

Trending